Position in QGEN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,804,719
New position
Shares Held
119,998
first reported quarter
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 95.58825980433006.ToString("F0")%
Shared 0.ToString("F0")%
None 4.411740195669927.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Capital Research Global Investors holds $4,311,389,109 across 6 Diagnostics & Research names. QGEN ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
4,414,621 | $2,169,918,660 | |
| 2 | DHR |
Danaher Corp /De/
|
8,897,773 | $1,687,017,760 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
781,345 | $439,029,942 | |
| 4 | WGS |
GeneDx Holdings Corp.
|
151,055 | $9,700,752 | |
| 5 | QGEN |
Qiagen N.V.
This page
|
119,998 | $4,804,719 | |
| 6 | RVTY |
Revvity, Inc.
|
10,470 | $917,276 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,804,719 | 119,998 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||